Bill
SB 114
Rhode Island establishes prescription drug pricing controls and supply chain transparency requirements to reduce medication costs for residents and state healthcare programs.
SB 114, Rhode Island's "Defending Affordable Prescription Drug Costs Act," establishes regulatory measures to control prescription drug pricing and increase transparency in the pharmaceutical supply chain. The bill, signed by the Governor on June 27, 2025, creates state-level oversight mechanisms to address rising medication costs for consumers and state healthcare programs.
Prescription drug costs represent a significant burden for Rhode Island residents and state budgets, particularly for chronically ill patients and seniors on fixed incomes. By implementing price controls and supply chain transparency requirements, the state aims to reduce out-of-pocket expenses and increase market predictability for healthcare providers and insurers. This reflects growing state-level action on drug pricing as federal reform efforts remain limited.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
